Bristol Myers reveals autoimmune CAR-T trial death, explains summertime pause
A patient has died in a Bristol Myers Squibb study of autoimmune CAR-T, the same technology that was called into question this summer when both Bristol Myers and Novartis paused similar programs. The patient, who ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.